Xylem price target raised to $147 from $143 at RBC Capital

RBC Capital raised the firm’s price target on Xylem (XYL) to $147 from $143 and keeps an Outperform rating on the shares. The company reported a solid operating beat and reiterated 2025 guidance now including tariffs, and the annualized tariff headwind at about 4% of COGS sounds manageable, the analyst tells investors in a research note. Xylem management called out two large project delays in microelectronics and energy/petrochem, but nothing broader, RBC adds.